...
首页> 外文期刊>International journal of hematology-oncology and stem cell research. >Efficient Differentiation of Human Induced Pluripotent Stem Cell (hiPSC) Derived Hepatocyte-Like Cells on hMSCs Feeder
【24h】

Efficient Differentiation of Human Induced Pluripotent Stem Cell (hiPSC) Derived Hepatocyte-Like Cells on hMSCs Feeder

机译:hMSCs饲养细胞上人诱导多能干细胞(hiPSC)衍生的肝细胞样细胞的高效分化

获取原文

摘要

BackgroundThe use of stem cells is considered as an appropriate source in cell therapy and tissue engineering. Differentiation of human induced Pluripotent Stem Cells (hiPSCs) to Hepatocyte-like Cells (HLCs) on mouse embryonic fibroblasts (MEFs) feeders is confronted with several problems that hinder the clinical applications of these differentiated cells for the treatment of liver injuries. Safe appropriate cells for stem cell-based therapies could create new hopes for liver diseases. This work focused on the determination of a capacity/efficiency for the differentiation of the hiPSCs into Hepatocyte-like Cells on a novel human adult bone marrow mesenchymal stem cells (hMSCs) feeder.Materials and MethodsUndifferentiated human iPSCs were cultured on mitotically inactivated human adult bone marrow mesenchymal stem cells. A three-step differentiation process has been performed in presence of activin A which added for 3 days to induce a definitive endoderm formation. In the second step, medium was exchanged for six days. Subsequently, cells were treated with oncostatin M plus dexamethasone for 9 days to generate hepatic cells. Endodermic and liver-specific genes were assessed via quantitative reverse transcription-polymerase chain reaction and RT-PCR, moreover, immunocytochemical staining for liver proteins including albumin and alpha-fetoprotein. In addition, functional tests for glycogen storage, oil red examination, urea production and alpha-fetoprotein synthesis, as well as, cells differentiated with a hepatocyte-like morphology was also performed.ResultsOur results show that inactivated human adult bone marrow mesenchymal stem cell feeders could support the efficient differentiation of hiPSCs into HLCs. This process induced differentiation of iPSCs into definitive endocrine cells that expressed sox17, foxa2 and expression of the specific genes profiles in hepatic-like cells. In addition, immunocytochemical analysis confirmed albumin and alpha-fetoprotein protein expression, as well as, the hiPSCs-derived Hepatocyte-like Cells on human feeder exhibited a typical morphology.Conclusionswe suggested a successful and efficient culture for differentiation and maturation of hepatocytes on an alternative human feeders; this is an important step to generate safe and functional hepatocytes that is vital for regenerative medicine and transplantation on the cell-based therapies.
机译:背景技术在细胞疗法和组织工程中,干细胞的使用被认为是适当的来源。人诱导的多能干细胞(hiPSC)向小鼠胚胎成纤维细胞(MEF)饲养器上的肝样细胞(HLC)的分化面临着一些问题,这些问题阻碍了这些分化细胞在肝损伤治疗中的临床应用。用于干细胞疗法的安全合适细胞可以为肝脏疾病创造新希望。这项工作的重点是确定新型人成体骨髓间充质干细胞(hMSCs)上hiPSCs分化为肝样细胞的能力/效率。骨髓间充质干细胞。在激活素A存在下进行了三步分化过程,激活素A加入3天以诱导确定的内胚层形成。第二步,更换培养基六天。随后,将细胞用制瘤素M加地塞米松处理9天以产生肝细胞。通过定量逆转录-聚合酶链反应和RT-PCR评估内胚层和肝脏特异性基因,此外,对肝蛋白(包括白蛋白和甲胎蛋白)进行免疫细胞化学染色。此外,还进行了糖原贮藏,油红检查,尿素生成和甲胎蛋白合成以及功能分化为肝细胞样形态的细胞的功能测试。结果我们的结果表明,灭活的人类成人骨髓间充质干细胞饲养细胞可以支持将hiPSC高效区分为HLC。此过程诱导iPSC分化为最终的内分泌细胞,该细胞表达sox17,foxa2并在肝样细胞中表达特定基因。此外,免疫细胞化学分析证实了白蛋白和甲胎蛋白蛋白的表达以及人类饲养细胞上的hiPSCs衍生的肝细胞样细胞均表现出典型的形态学。人工喂食器;这是产生安全和功能性肝细胞的重要步骤,这对于再生医学和基于细胞的疗法的移植至关重要。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号